FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely to the method for destruction of M.P. Pokrovskaya’s bacteriophage nucleocapsid. The method for destruction of M.P. Pokrovskaya’s bacteriophage nucleocapsid includes the preparation of a means for implementing the proposed method, including the preparation of Sky Force dissolved in distilled water at a concentration of 100 micrograms of Sky Force per 1 ml of distilled water; preparation of a suspension of M.P. Pokrovskaya’s bacteriophage on an isotonic solution of sodium chloride at a concentration of 1×109 phage particles in 1 ml; introduction of the prepared bacteriophage suspension into a vial with a solution of the Sky Force preparation in such a way that the concentration of phage particles in the reaction mixture is 1×108 in 1 ml, and the concentration of the Sky Force preparation is 100 micrograms in 1 ml; sampling of the reaction mixture with destroyed phage particles after 10-20 minutes and its examination using electron microscopy devices.
EFFECT: method described above makes it possible to effectively carry out the destruction of M.P. Pokrovskaya’s nucleocapsid of the bacteriophage.
1 cl, 3 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
TEST SYSTEM AND METHOD FOR DIFFERENTIAL DETECTION OF ANTIBODIES TO SARS-COV-2 | 2021 |
|
RU2754340C1 |
PEPTIDE IMMUNOGENS AND VACCINE COMPOSITION AGAINST COVID-19 WITH THE USE OF PEPTIDE IMMUNOGENS | 2020 |
|
RU2743593C1 |
PEPTIDE IMMUNOGENS USED AS COMPONENTS OF VACCINE COMPOSITION AGAINST COVID-19 | 2020 |
|
RU2743594C1 |
PEPTIDE IMMUNOGENS AND A VACCINE COMPOSITION AGAINST CORONAVIRUS INFECTION COVID-19 USING PEPTIDE IMMUNOGENS | 2020 |
|
RU2738081C1 |
VACCINE COMPOSITION AGAINST COVID-19 | 2020 |
|
RU2743595C1 |
STRAIN OF HCOV-19/RUSSIA/OMSK-202118-1707/2020 OF SARS-COV-2 CORONAVIRUS, IMMUNOSORBENT CONTAINING PURIFIED WHOLE VIRION ANTIGEN OBTAINED ON BASIS OF SPECIFIED STRAIN AND ISA TEST SYSTEM FOR DETECTING ANTIBODIES OF CLASSES M, G AND A TO SARS CORONAVIRUS-COV-2 USING SPECIFIED IMMUNOSORBENT | 2021 |
|
RU2752862C1 |
METHOD FOR COMPLEX THERAPY OF PEDIATRIC PATIENTS WITH VIRAL INFECTION USING PROBIOTIC FOOD PRODUCTS | 2021 |
|
RU2793833C1 |
RECOMBINANT PROTEIN FOR IMMUNIZATION AGAINST FELINE CORONAVIRUS | 2023 |
|
RU2808965C1 |
METHOD FOR PREVENTION OR TREATMENT OF CORONAVIRUS AND OTHER ACUTE RESPIRATORY VIRAL INFECTIONS | 2022 |
|
RU2794315C1 |
MEFLOQUINE AND COMBINATIONS THEREOF FOR TREATING AND PREVENTING A CORONAVIRUS INFECTION | 2020 |
|
RU2763024C1 |
Authors
Dates
2021-11-02—Published
2021-05-11—Filed